These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7911317)

  • 21. The importance of dose: lymphomas as a model of chemosensitive malignancies.
    Bronchud MH
    Eur J Cancer; 1993; 29A Suppl 5():S17-22. PubMed ID: 8260261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.
    Davidson KL; Devaney MB; Tighe JE; Rogers SY; Dunlop DJ; Mackie MJ; Thomas RV; Johnson PR;
    Haematologica; 2003 Dec; 88(12):1366-71. PubMed ID: 14687989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
    Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
    Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.
    Williams CD; Harrison CN; Lister TA; Norton AJ; Blystad AK; Coiffier B; Taghipour G; Schmitz N; Goldstone AH;
    J Clin Oncol; 2001 Feb; 19(3):727-35. PubMed ID: 11157024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients.
    Kessinger A; Vose JM; Bierman PJ; Bishop M; Armitage JO
    J Hematother; 1993; 2(3):361-2. PubMed ID: 7921996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of advanced bladder cancer.
    Sternberg CN
    Ann Oncol; 1995 Feb; 6(2):113-26. PubMed ID: 7786818
    [No Abstract]   [Full Text] [Related]  

  • 27. Haemopoietic growth factors.
    Ketley NJ; Newland AC
    Postgrad Med J; 1997 Apr; 73(858):215-21. PubMed ID: 9156123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tandem high-dose therapy followed by autologous stem-cell transplantation for refractory or relapsed high grade non-Hodgkin's lymphoma with poor prognosis factors: a prospective pilot study.
    Le Gouill S; Moreau P; Morineau N; Harousseau JL; Milpied N
    Haematologica; 2002 Mar; 87(3):333-4. PubMed ID: 11869953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indications for early autologous stem cell transplantation in aggressive lymphoma.
    Kluin-Nelemans HC
    Ann Hematol; 2001; 80 Suppl 3():B121-2. PubMed ID: 11757692
    [No Abstract]   [Full Text] [Related]  

  • 30. Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review.
    Haw R; Sawka CA; Franssen E; Berinstein NL
    J Clin Oncol; 1994 May; 12(5):1074-84. PubMed ID: 8164032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M
    Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rationale of therapy with mitoxantrone in non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Co-operative Study Group, (NHLCSG) Italy.
    Chisesi T
    Leuk Lymphoma; 1993 Jan; 9(1-2):63-9. PubMed ID: 8477203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma.
    Kriegsmann K; Rieger M; Schwarzbich MA; Sitter S; Kriegsmann M; Bruckner T; Hensel M; Ho AD; Witzens-Harig M; Wuchter P
    Eur J Haematol; 2018 Jul; 101(1):12-20. PubMed ID: 29575332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.
    Philip T; Guglielmi C; Hagenbeek A; Somers R; Van der Lelie H; Bron D; Sonneveld P; Gisselbrecht C; Cahn JY; Harousseau JL
    N Engl J Med; 1995 Dec; 333(23):1540-5. PubMed ID: 7477169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation.
    Tsai D; Moore H; Hardy C; Porter D; Loh E; Vaughn D; Luger S; Schuster S; Stadtmauer E
    Bone Marrow Transplant; 1999 Sep; 24(5):521-6. PubMed ID: 10482937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
    Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
    Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of hematopoietic growth factors in transfusion medicine.
    Whitsett CF
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):23-68. PubMed ID: 7737944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etoposide, mitoxantrone and prednisone: a salvage regimen with low toxicity for refractory or relapsed non-Hodgkin's lymphoma.
    Doorduijn JK; Spruit P; van Der Holt B; van't Veer M; Budel L; Löwenberg B; Sonneveld P
    Haematologica; 2000 Aug; 85(8):814-9. PubMed ID: 10942927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival of patients with resistant lymphoma treated with tandem stem cell transplant.
    Ahmed T; Rashid K; Waheed F; Kancherla R; Qureshi Z; Hoang A; Richter J; Ali MF; Goldberg R; Liu D; Seiter K
    Leuk Lymphoma; 2005 Mar; 46(3):405-14. PubMed ID: 15621831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: the EBMT experience. Lymphoma Working Party of the European Group for Bone Marrow Transplantation.
    Sweetenham JW; Proctor SJ; Blaise D; De Laurenzi A; Pearce R; Taghipour G; Goldstone AH; Laurenzi A [corrected to De Laurenzi A]
    Ann Oncol; 1994; 5 Suppl 2():155-9. PubMed ID: 7515646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.